<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Mediators Inflamm</journal-id><journal-id journal-id-type="publisher-id">MI</journal-id><journal-title>Mediators of Inflammation</journal-title><issn pub-type="ppub">0962-9351</issn><issn pub-type="epub">1466-1861</issn><publisher><publisher-name>Hindawi Publishing Corporation</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.1155/2007/93431</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Progesterone Prevents Traumatic Brain Injury-Induced Intestinal Nuclear Factor kappa B Activation and Proinflammatory Cytokines Expression in Male Rats</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Chen</surname><given-names>Gang</given-names></name><xref ref-type="aff" rid="I1"/></contrib><contrib contrib-type="author"><name><surname>Shi</surname><given-names>Jinxin</given-names></name><xref ref-type="aff" rid="I1"/></contrib><contrib contrib-type="author"><name><surname>Ding</surname><given-names>Yasuo</given-names></name><xref ref-type="aff" rid="I1"/></contrib><contrib contrib-type="author"><name><surname>Yin</surname><given-names>Hongxia</given-names></name><xref ref-type="aff" rid="I1"/></contrib><contrib contrib-type="author"><name><surname>Hang</surname><given-names>Chunhua</given-names></name><xref ref-type="aff" rid="I1"/><xref ref-type="corresp" rid="cor1">*</xref></contrib></contrib-group><aff id="I1">Department of Neurosurgery, Jinling Hospital, School of Medicine, Nanjing University, Nanjing, Jiangsu Province 210002, China</aff><author-notes><corresp id="cor1">*Chunhua Hang: <email>nju_neurosurgery@163.com</email></corresp></author-notes><pub-date pub-type="ppub"><year>2007</year></pub-date><pub-date pub-type="epub"><day>20</day><month>8</month><year>2007</year></pub-date><volume>2007</volume><elocation-id>93431</elocation-id><history><date date-type="received"><day>29</day><month>4</month><year>2007</year></date><date date-type="accepted"><day>2</day><month>7</month><year>2007</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2007 Gang Chen et al.</copyright-statement><copyright-year>2007</copyright-year><license license-type="open-access"><p>This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p></license></permissions><abstract><p>We have previously shown that traumatic brain injury (TBI) can induce an upregulation of nuclear factor kappa B (NF-<inline-formula><mml:math id="M1"><mml:mrow><mml:mi>&#x003ba;</mml:mi></mml:mrow></mml:math></inline-formula>B) and proinflammatory cytokines in the gut, which play an important role in the pathogenesis of acute gut mucosal injury mediated by inflammation. In this work, we investigated whether progesterone administration modulated intestinal NF-<inline-formula><mml:math id="M2"><mml:mrow><mml:mi>&#x003ba;</mml:mi></mml:mrow></mml:math></inline-formula>B activity and proinflammatory cytokines expression after TBI in male rats. As a result, we found that administration of progesterone following TBI could decrease NF-<inline-formula><mml:math id="M3"><mml:mrow><mml:mi>&#x003ba;</mml:mi></mml:mrow></mml:math></inline-formula>B binding activity, NF-<inline-formula><mml:math id="M4"><mml:mrow><mml:mi>&#x003ba;</mml:mi></mml:mrow></mml:math></inline-formula>B p65 protein expression, and concentrations of interleukin-<inline-formula><mml:math id="M5"><mml:mrow><mml:mn>1</mml:mn><mml:mi>&#x003b2;</mml:mi></mml:mrow></mml:math></inline-formula> (IL-<inline-formula><mml:math id="M6"><mml:mrow><mml:mn>1</mml:mn><mml:mi>&#x003b2;</mml:mi></mml:mrow></mml:math></inline-formula>), and tumor necrosis factor-<inline-formula><mml:math id="M7"><mml:mrow><mml:mi>&#x003b1;</mml:mi></mml:mrow></mml:math></inline-formula> (TNF-<inline-formula><mml:math id="M8"><mml:mrow><mml:mi>&#x003b1;</mml:mi></mml:mrow></mml:math></inline-formula>) in the gut. TBI-induced damages of gut structure were ameliorated after progesterone injections. The results of the present study suggest that the therapeutic benefit of post-TBI progesterone injections might be due to its inhibitory effects on intestinal NF-<inline-formula><mml:math id="M9"><mml:mrow><mml:mi>&#x003ba;</mml:mi></mml:mrow></mml:math></inline-formula>B activation and proinflammatory cytokines expression.</p></abstract></article-meta></front><body><sec sec-type="section" id="sec1"><title>1. INTRODUCTION</title><p>The importance of the intestinal mucosa in the inflammatory and metabolic responses to sepsis, trauma, and other critical illnesses is increasingly recognized. Major trauma and shock may initiate a cascade of intestinal events such as intestinal cytokine overproduction [<xref ref-type="bibr" rid="B1">1</xref>], increased intestinal permeability [<xref ref-type="bibr" rid="B2">2</xref>], and translocation of intestinal bacteria and endotoxins [<xref ref-type="bibr" rid="B3">3</xref>]. These events may not only influence the intestinal mucosa itself, but also may affect the function and integrity of remote organs and tissues, leading to systemic inflammatory response syndrome (SIRS) and multiple organ dysfunction syndrome (MODS). In our previous study [<xref ref-type="bibr" rid="B4">4</xref>], it has been demonstrated that traumatic brain injury (TBI) can induce marked damage of intestinal mucosa structure including the shedding of epithelial cells, fracture of villi, focal ulceration, fusion of adjacent villi, dilation of the central chyle duct, mucosal atrophy, and disruption of the tight junction between enterocytes. Afterwards, we found that inflammatory response mediated by increased nuclear factor kappa B (NF-<inline-formula><mml:math id="M10"><mml:mrow><mml:mi>&#x003ba;</mml:mi></mml:mrow></mml:math></inline-formula>B) and proinflammatory cytokines played a crucial pathological role in acute gut mucosal injury following TBI [<xref ref-type="bibr" rid="B5">5</xref>]. However, little information was found in the literatures about any effective treatment that could modulate intestinal NF-<inline-formula><mml:math id="M11"><mml:mrow><mml:mi>&#x003ba;</mml:mi></mml:mrow></mml:math></inline-formula>B activation and proinflammatory cytokines production after TBI.</p><p>Since its identification as an inducible activator of gene transcription from the intronic <inline-formula><mml:math id="M12"><mml:mrow><mml:mi>&#x003ba;</mml:mi></mml:mrow></mml:math></inline-formula> light chain, the nuclear transcription factor, NF-<inline-formula><mml:math id="M13"><mml:mrow><mml:mi>&#x003ba;</mml:mi></mml:mrow></mml:math></inline-formula>B, has been implicated in the regulation of a growing number of gene products that contribute to the pathogenesis of numerous clinical disorders [<xref ref-type="bibr" rid="B6">6</xref>]. NF-<inline-formula><mml:math id="M14"><mml:mrow><mml:mi>&#x003ba;</mml:mi></mml:mrow></mml:math></inline-formula>B functions as homo- or heterodimers of the Rel family of proteins, which includes p50, p65, c-Rel, p52, and RelB [<xref ref-type="bibr" rid="B7">7</xref>]. The most common combination of subunits is a hererodimer of the p50 and p65 proteins. NF-<inline-formula><mml:math id="M15"><mml:mrow><mml:mi>&#x003ba;</mml:mi></mml:mrow></mml:math></inline-formula>B normally exists in the cytoplasm of cells bound by a member of the inhibitor kappa B (I-<inline-formula><mml:math id="M16"><mml:mrow><mml:mi>&#x003ba;</mml:mi></mml:mrow></mml:math></inline-formula>B) protein family. NF-<inline-formula><mml:math id="M17"><mml:mrow><mml:mi>&#x003ba;</mml:mi></mml:mrow></mml:math></inline-formula>B activation by inducers, such as IL-1<inline-formula><mml:math id="M18"><mml:mrow><mml:mi>&#x003b2;</mml:mi></mml:mrow></mml:math></inline-formula> [<xref ref-type="bibr" rid="B7">7</xref>, <xref ref-type="bibr" rid="B8">8</xref>] and TNF-<inline-formula><mml:math id="M19"><mml:mrow><mml:mi>&#x003b1;</mml:mi></mml:mrow></mml:math></inline-formula> [<xref ref-type="bibr" rid="B9">9</xref>], leads to phosphorylation and degration of the I-<inline-formula><mml:math id="M20"><mml:mrow><mml:mi>&#x003ba;</mml:mi></mml:mrow></mml:math></inline-formula>B protein allowing NF-<inline-formula><mml:math id="M21"><mml:mrow><mml:mi>&#x003ba;</mml:mi></mml:mrow></mml:math></inline-formula>B translocation to the nucleus where it can then bind to specific sites within the promoter sequence of target genes whose products, such as proinflammatory cytokines, inducible nitric oxide synthase (iNOS), cyclooxygenase-2 (COX-2), and acute phase proteins, are critical to inflammatory processes [<xref ref-type="bibr" rid="B10">10</xref>, <xref ref-type="bibr" rid="B11">11</xref>]. This kind of positive feedback in the interaction of NF-<inline-formula><mml:math id="M22"><mml:mrow><mml:mi>&#x003ba;</mml:mi></mml:mrow></mml:math></inline-formula>B with proinflammatory cytokines may occur through extracellular mechanisms, which has been confirmed by several studies [<xref ref-type="bibr" rid="B12">12</xref>, <xref ref-type="bibr" rid="B13">13</xref>]. NF-<inline-formula><mml:math id="M23"><mml:mrow><mml:mi>&#x003ba;</mml:mi></mml:mrow></mml:math></inline-formula>B activation enhances the transcription of TNF-<inline-formula><mml:math id="M24"><mml:mrow><mml:mi>&#x003b1;</mml:mi></mml:mrow></mml:math></inline-formula> and IL-1<inline-formula><mml:math id="M25"><mml:mrow><mml:mi>&#x003b2;</mml:mi></mml:mrow></mml:math></inline-formula>, and both of these cytokines are known to in turn activate NF-<inline-formula><mml:math id="M26"><mml:mrow><mml:mi>&#x003ba;</mml:mi></mml:mrow></mml:math></inline-formula>B [<xref ref-type="bibr" rid="B14">14</xref>]. The positive feedback is believed to serve to amplify inflammatory signals.</p><p>Several experimental studies have demonstrated that progesterone played neuroprotective roles in TBI including reducing cerebral edema, preventing neuronal loss, and improving functional outcomes [<xref ref-type="bibr" rid="B15">15</xref>, <xref ref-type="bibr" rid="B16">16</xref>]. One of the specific mechanisms by which progesterone acts to promote morphological and functional recovery is via inhibiting the TBI-induced cerebral NF-<inline-formula><mml:math id="M27"><mml:mrow><mml:mi>&#x003ba;</mml:mi></mml:mrow></mml:math></inline-formula>B activation and proinflammatory cytokines up-regulation [<xref ref-type="bibr" rid="B17">17</xref>, <xref ref-type="bibr" rid="B18">18</xref>]. Nevertheless till now, no study was found in the literature to investigate the effects of progesterone on intestinal expression of NF-<inline-formula><mml:math id="M28"><mml:mrow><mml:mi>&#x003ba;</mml:mi></mml:mrow></mml:math></inline-formula>B and proinflammatory cytokines. In the present study, we investigated the influence of progesterone administration on NF-<inline-formula><mml:math id="M29"><mml:mrow><mml:mi>&#x003ba;</mml:mi></mml:mrow></mml:math></inline-formula>B activity and proinflammatory cytokines expression in the small bowl following TBI in male rats.</p></sec><sec sec-type="section" id="sec2"><title>2. MATERIALS AND METHODS</title><sec sec-type="subsection" id="subsec2.1"><title>2.1. Animals</title><p>Male Wistar rats (300 to 350&#x02009;g) were purchased from Animal Center of Chinese Academy of Sciences, Shanghai, China. The rats were housed in temperature and humidity controlled animal quarters with a 12-hour light/dark cycle. All procedures were approved by the Institutional Animal Care Committee and were in accordance with the guidelines of the National Institutes of Health on the care and use of animals.</p></sec><sec sec-type="subsection" id="subsec2.2"><title>2.2. Experiment protocol</title><p>Rat model of cortical contusion trauma: following intraperitoneal anesthesia with urethane (1000&#x02009;mg/kg), animal head was fixed in the stereotactic frame. A right parietal craniotomy (diameter 5&#x02009;mm) was drilled under aseptic conditions 1&#x02009;mm posterior and 2&#x02009;mm lateral to the bregma. We used a modification of the Feeney's weight-drop model [<xref ref-type="bibr" rid="B19">19</xref>] in which a freefalling weight onto the exposed intact cranial dura produced a standardized parietal contusion by letting a steel rod weighing 40&#x02009;g with a flat end diameter of 4&#x02009;mm fall onto a piston resting on the dura from a height of 25&#x02009;cm. The piston was allowed to compress the tissue a maximum of 5&#x02009;mm. After operation procedures, the rats were then returned to their cages and the room temperature was kept at <inline-formula><mml:math id="M30"><mml:mrow><mml:mn>23</mml:mn><mml:mo>&#x000b1;</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:math></inline-formula>&#x000b0;C. Heart rate, arterial blood pressure and rectal temperature were monitored, and the rectal temperature was kept at <inline-formula><mml:math id="M31"><mml:mrow><mml:mn>37</mml:mn><mml:mo>&#x000b1;</mml:mo><mml:mn>0.5</mml:mn></mml:mrow></mml:math></inline-formula>&#x000b0;C, by using physical cooling (ice bag) when required, throughout experiments. Sham-operated rats were anesthetized, mounted in the stereotaxic apparatus, and had their scalps cut and sutured but were not trephinated.</p><p>The experimental groups consisted of sham + vehicle (SV; <inline-formula><mml:math id="M32"><mml:mrow><mml:mi>n</mml:mi><mml:mo>=</mml:mo><mml:mn>6</mml:mn></mml:mrow></mml:math></inline-formula>), lesion + vehicle (LV; <inline-formula><mml:math id="M33"><mml:mrow><mml:mi>n</mml:mi><mml:mo>=</mml:mo><mml:mn>6</mml:mn></mml:mrow></mml:math></inline-formula>), and lesion + progesterone (LP; <inline-formula><mml:math id="M34"><mml:mrow><mml:mi>n</mml:mi><mml:mo>=</mml:mo><mml:mn>6</mml:mn></mml:mrow></mml:math></inline-formula>). Rats of LP group received injections of 16&#x02009;mg/kg progesterone (4-Pregnene-3, 20-dione, Sigma-aldrich Inc., St. Louis, MO, USA) at 1 and 6 hours and 1, 2, 3, 4, and 5 days after the surgery (intraperitoneally for the first and subcutaneously for the remaining six). Rats of SV and LV groups received equal volumes of vehicle (2-hydroxypropyl-<inline-formula><mml:math id="M35"><mml:mrow><mml:mi>&#x003b2;</mml:mi></mml:mrow></mml:math></inline-formula>-cyclodextrin, Sigma-aldrich Inc.) [<xref ref-type="bibr" rid="B20">20</xref>, <xref ref-type="bibr" rid="B21">21</xref>]. The animals were decapitated 5 days after injury for tissue assays. A 3-cm segment of the mid-ileum was taken and flushed with ice-cold saline. Half of it was immersed in neutral-buffered formalin for immunohistochemical assay and histopathological study. The other was stored in liquid nitrogen immediately for electrophoretic mobility shift assay (EMSA) and enzyme-linked immunosorbent assay (ELISA).</p></sec><sec sec-type="subsection" id="subsec2.3"><title>2.3. Nuclear protein extract and EMSA</title><p>Nuclear protein was extracted and quantified as described [<xref ref-type="bibr" rid="B5">5</xref>]. EMSA was performed using a commercial kit (Gel Shift Assay System; Promega, Madison, WI, USA) following the methods in our laboratory. The NF-<inline-formula><mml:math id="M36"><mml:mrow><mml:mi>&#x003ba;</mml:mi></mml:mrow></mml:math></inline-formula>B oligonucleotide probe (5&#x02032;-AGTTGAGGGGACTTTCCCAGGC-3&#x02032;) was end-labeled with [<inline-formula><mml:math id="M37"><mml:mrow><mml:mi>&#x003b3;</mml:mi></mml:mrow></mml:math></inline-formula>-<sup>32</sup>P] ATP (Free Biotech, Beijing, China). EMSA was performed according to our previous study [<xref ref-type="bibr" rid="B5">5</xref>]. After electrophoresis, the gel was transferred to Whatman filter paper, vacuum dried and exposed to Kodak XAR-5 film overnight. Levels of NF-<inline-formula><mml:math id="M38"><mml:mrow><mml:mi>&#x003ba;</mml:mi></mml:mrow></mml:math></inline-formula>B DNA binding activity were quantified by scanning the developed Kodak XAR-5 film with a computer-assisted, linear scanning densitometer in transparent mode (Hoefer Scientific Instruments, San Francisco, CA, USA). Data were expressed as arbitrary densitometry units (ADU) obtained from the densitometric scans.</p></sec><sec sec-type="subsection" id="subsec2.4"><title>2.4. Detection of NF-<inline-formula><mml:math id="M39"><mml:mrow><mml:mi>&#x003ba;</mml:mi></mml:mrow></mml:math></inline-formula>B p65 and p50 expression in ileum tissue</title><p>Immunohistochemical studies were conducted on formalin-fixed, paraffin-embedded sections. The rabit-anti-rat monoclonal antibodies of NF-<inline-formula><mml:math id="M40"><mml:mrow><mml:mi>&#x003ba;</mml:mi></mml:mrow></mml:math></inline-formula>B p65 and p50 (both diluted 1 : 100, Santa Cruz Biotechnology, Inc., CA, USA) were used. For immunohistochemistry, sections were incubated in phosphate-buffered saline (PBS) with 5% normal horse serum and 0.3% Triton X-100 for 1 hour at room temperature. Sections were washed three times with PBS and incubated with primary antibody for 2 hours at room temperature. After washing with PBS, sections were incubated with biotinylated second antibodies for 1 hour at room temperature. Sections incubated in the absence of primary antibody were used as negative controls. Microscopy of the immunohistochemically stained tissue sections was performed by an experienced pathologist blinded to the experimental condition. Therfore, evaluation of sections was undertaken by assessing the intensity of staining (5 grades). &#x0201c;0&#x0201d; indicates that there were no detectable positive cells; &#x0201c;1&#x0201d; indicates very low density of positive cells; &#x0201c;2&#x0201d; indicates a moderate density of positive cells; &#x0201c;3&#x0201d; indicates the higher, but not maximal density of positive cells; and &#x0201c;4&#x0201d; indicates the highest density of positive cells.</p></sec><sec sec-type="subsection" id="subsec2.5"><title>2.5. Detection of IL-1<inline-formula><mml:math id="M41"><mml:mrow><mml:mi>&#x003b2;</mml:mi></mml:mrow></mml:math></inline-formula> and TNF-<inline-formula><mml:math id="M42"><mml:mrow><mml:mi>&#x003b1;</mml:mi></mml:mrow></mml:math></inline-formula> in ileum tissue</title><p>The frozen ileum tissue was homogenized with a glass homogenizer in 1&#x02009;ml of buffer containing 1&#x02009;mmol/L of PMSF, 1&#x02009;mg/L of pepstatin A, 1&#x02009;mg/L of aprotinin, and 1&#x02009;mg/L of leupeptin in PBS solution (pH 7.2) and centrifuged at 12,000&#x02009;g. for 20 minutes at 4&#x000b0;C. The intestinal levels of inflammatory mediators were quantified using specific ELISA kits for rats according to the manufacturers' instructions (TNF-<inline-formula><mml:math id="M43"><mml:mrow><mml:mi>&#x003b1;</mml:mi></mml:mrow></mml:math></inline-formula> from Diaclone Research, France; IL-1<inline-formula><mml:math id="M44"><mml:mrow><mml:mi>&#x003b2;</mml:mi></mml:mrow></mml:math></inline-formula> from Biosource Europe SA, Belgium). The cytokine contents in the ileum tissue were expressed as nanograms of cytokines per gram of protein.</p></sec><sec sec-type="subsection" id="subsec2.6"><title>2.6. Histopathological examination</title><p>The neutral-buffered formalin-fixed ileum was embedded in paraffin, sectioned at 4&#x02009;<italic>&#x003bc;</italic>m thickness with a microtome and stained with hematoxylin and eosin (H and E). The sections were examined under light microscope. Villous height, diameter of middle villous segment, and crypt depth in all tissues were determined using the HPIAS-1000 colorful image analysis system (Champion Image Engineering Company, Wuhan, China) [<xref ref-type="bibr" rid="B4">4</xref>]. Villous surface area was calculated according to the following formula: surface area = <inline-formula><mml:math id="M45"><mml:mrow><mml:mi>&#x003c0;</mml:mi></mml:mrow></mml:math></inline-formula>dh (d, diameter; h, villous height). At least 10 well-oriented crypt-villous units per small intestinal sample were measured and averaged by a pathologist who was blind to animal groups.</p></sec><sec sec-type="subsection" id="subsec2.7"><title>2.7. Statistical analysis</title><p>The data were presented as mean &#x000b1; SD. SPSS 12.0 was used for statistical analysis of the data. The comparisons of NF-<inline-formula><mml:math id="M47"><mml:mrow><mml:mi>&#x003ba;</mml:mi></mml:mrow></mml:math></inline-formula>B p65 and p50 grades among various groups were conducted by using Mann-Whitney U test. The other measurements were analyzed by one-way ANOVA, followed by Tukey <italic>post hoc</italic> test. Statistical significance was inferred at <inline-formula><mml:math id="M48"><mml:mrow><mml:mi>P</mml:mi><mml:mo>&#x02062;</mml:mo><mml:mo>&#x0003c;</mml:mo><mml:mtext>&#x02009;</mml:mtext><mml:mn>.05</mml:mn></mml:mrow></mml:math></inline-formula>.</p></sec></sec><sec sec-type="section" id="sec3"><title>3. RESULTS</title><sec sec-type="subsection" id="subsec3.1"><title>3.1. General observations</title><p>Rats in SV group usually recover consciousness during 12 hours after anesthesia and sham operation, whereas rats in both LV and LP groups were temporally unconscious for 48 hours post-injury and recovered almost normal eating behavior from 72 hours after cortical contusion trauma. During the period of unconsciousness, the rats were given 3&#x02009;ml of water per 6 hours by tube feeding. After the right parietal cortical contusion, the rats failed to fully extend the left forepaw. The mean arterial blood pressure values and body temperature were within the normal physiological range for all animals (data not shown). The mean baseline weight of the rats in the three groups did not significantly differ before injury.</p></sec><sec sec-type="subsection" id="subsec3.2"><title>3.2. NF-<inline-formula><mml:math id="M49"><mml:mrow><mml:mi>&#x003ba;</mml:mi></mml:mrow></mml:math></inline-formula>B binding activity in the ileum tissue</title><p>EMSA autoradiography of NF-<inline-formula><mml:math id="M50"><mml:mrow><mml:mi>&#x003ba;</mml:mi></mml:mrow></mml:math></inline-formula>B DNA binding activity of the ileum tissue samples was shown in <xref ref-type="fig" rid="fig1">Figure 1</xref>. Low NF-<inline-formula><mml:math id="M51"><mml:mrow><mml:mi>&#x003ba;</mml:mi></mml:mrow></mml:math></inline-formula>B binding activity (weak EMSA autoradiography) was found in the SV group. Compared with SV group, NF-<inline-formula><mml:math id="M52"><mml:mrow><mml:mi>&#x003ba;</mml:mi></mml:mrow></mml:math></inline-formula>B binding activity in the small bowl was significantly increased <inline-formula><mml:math id="M53"><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi>P</mml:mi><mml:mo>&#x02062;</mml:mo><mml:mo>&#x0003c;</mml:mo><mml:mtext>&#x02009;</mml:mtext><mml:mn>.01</mml:mn></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:math></inline-formula> in LV group. In LP group, intestinal NF-<inline-formula><mml:math id="M54"><mml:mrow><mml:mi>&#x003ba;</mml:mi></mml:mrow></mml:math></inline-formula>B binding activity was significantly down-regulated <inline-formula><mml:math id="M55"><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi>P</mml:mi><mml:mo>&#x02062;</mml:mo><mml:mo>&#x0003c;</mml:mo><mml:mtext>&#x02009;</mml:mtext><mml:mn>.05</mml:mn></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:math></inline-formula> after progesterone injections.</p></sec><sec sec-type="subsection" id="subsec3.3"><title>3.3. Expression of NF-<inline-formula><mml:math id="M56"><mml:mrow><mml:mi>&#x003ba;</mml:mi></mml:mrow></mml:math></inline-formula>B p65 and p50 in ileum tissue</title><p>The immunohistochemical assay showed lower NF-<inline-formula><mml:math id="M57"><mml:mrow><mml:mi>&#x003ba;</mml:mi></mml:mrow></mml:math></inline-formula>B p65 immunoreactivity in the lamina propia of the mucosa and the interstitial region in SV group (see <xref ref-type="fig" rid="fig2">Figure 2</xref>). Compared to SV group, NF-<inline-formula><mml:math id="M58"><mml:mrow><mml:mi>&#x003ba;</mml:mi></mml:mrow></mml:math></inline-formula>B p65 was significantly up-regulated <inline-formula><mml:math id="M59"><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi>P</mml:mi><mml:mo>&#x02062;</mml:mo><mml:mo>&#x0003c;</mml:mo><mml:mtext>&#x02009;</mml:mtext><mml:mn>.01</mml:mn></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:math></inline-formula> in villous interstitium and lamina propria following TBI (see Figures <xref ref-type="fig" rid="fig2">2</xref> and <xref ref-type="fig" rid="fig4">4</xref>). In LP group, the number of NF-<inline-formula><mml:math id="M60"><mml:mrow><mml:mi>&#x003ba;</mml:mi></mml:mrow></mml:math></inline-formula>B p65 immunoreactivity was significantly decreased <inline-formula><mml:math id="M61"><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi>P</mml:mi><mml:mo>&#x02062;</mml:mo><mml:mo>&#x0003c;</mml:mo><mml:mtext>&#x02009;</mml:mtext><mml:mn>.05</mml:mn></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:math></inline-formula> (see Figures <xref ref-type="fig" rid="fig2">2</xref> and <xref ref-type="fig" rid="fig4">4</xref>). The results showed that progesterone administration could significantly down-regulate the NF-<inline-formula><mml:math id="M62"><mml:mrow><mml:mi>&#x003ba;</mml:mi></mml:mrow></mml:math></inline-formula>B p65 immunoreactivity in rat intestine following TBI (see Figures <xref ref-type="fig" rid="fig2">2</xref> and <xref ref-type="fig" rid="fig4">4</xref>). The NF-<inline-formula><mml:math id="M63"><mml:mrow><mml:mi>&#x003ba;</mml:mi></mml:mrow></mml:math></inline-formula>B p50 expression in ileum was not significantly different among groups of SV, LV, and LP, in which there were very low NF-<inline-formula><mml:math id="M64"><mml:mrow><mml:mi>&#x003ba;</mml:mi></mml:mrow></mml:math></inline-formula>B p50 immunoreactivity in the villous interstitium and lamina propria (see Figures <xref ref-type="fig" rid="fig3">3</xref> and <xref ref-type="fig" rid="fig4">4</xref>).</p></sec><sec sec-type="subsection" id="subsec3.4"><title>3.4. Intestinal levels of IL-1<inline-formula><mml:math id="M65"><mml:mrow><mml:mi>&#x003b2;</mml:mi></mml:mrow></mml:math></inline-formula> and TNF-<inline-formula><mml:math id="M66"><mml:mrow><mml:mi>&#x003b1;</mml:mi></mml:mrow></mml:math></inline-formula></title><p>Concentrations of IL-1<inline-formula><mml:math id="M67"><mml:mrow><mml:mi>&#x003b2;</mml:mi></mml:mrow></mml:math></inline-formula> and TNF-<inline-formula><mml:math id="M68"><mml:mrow><mml:mi>&#x003b1;</mml:mi></mml:mrow></mml:math></inline-formula> were low in the rat gut of SV group (<inline-formula><mml:math id="M69"><mml:mn>1.85</mml:mn><mml:mo>&#x000b1;</mml:mo><mml:mn>0.56</mml:mn></mml:math></inline-formula> and <inline-formula><mml:math id="M70"><mml:mn>2.23</mml:mn><mml:mo>&#x000b1;</mml:mo><mml:mn>0.21</mml:mn></mml:math></inline-formula>&#x02009;ng/g protein, resp.) (see <xref ref-type="fig" rid="fig5">Figure 5</xref>). Compared with SV group, intestinal levels of the two inflammatory cytokines were greatly induced after TBI. As shown in <xref ref-type="fig" rid="fig5">Figure 5</xref>, progesterone administration after TBI could lead to significantly decreased IL-1<inline-formula><mml:math id="M71"><mml:mrow><mml:mi>&#x003b2;</mml:mi></mml:mrow></mml:math></inline-formula> and TNF-<inline-formula><mml:math id="M72"><mml:mrow><mml:mi>&#x003b1;</mml:mi></mml:mrow></mml:math></inline-formula> concentrations <inline-formula><mml:math id="M73"><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi>P</mml:mi><mml:mo>&#x02062;</mml:mo><mml:mo>&#x0003c;</mml:mo><mml:mtext>&#x02009;</mml:mtext><mml:mn>.05</mml:mn></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:math></inline-formula> in rat ileum tissue.</p></sec><sec sec-type="subsection" id="subsec3.5"><title>3.5. Histomorphometric studies</title><p>Villous height, crypt depth, and villous surface area were determined as specific indices for the evaluation of mucosal damages. The parameters are shown in <xref ref-type="table" rid="tab1">Table 1</xref>. Quantitative analyses of the villi demonstrated that the villous height and crypt depth were significantly decreased in LV group as compared with SV group <inline-formula><mml:math id="M74"><mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi>P</mml:mi><mml:mo>&#x0003c;</mml:mo><mml:mn>.05</mml:mn></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula>. In LP group, villous height and crypt depth were increased significantly as compared with LV group <inline-formula><mml:math id="M75"><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi>P</mml:mi><mml:mo>&#x02062;</mml:mo><mml:mo>&#x0003c;</mml:mo><mml:mtext>&#x02009;</mml:mtext><mml:mn>.01</mml:mn></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:math></inline-formula>. Although villous surface area was not decreased significantly in LV group, the intestinal villous surface area was increased significantly after progesterone injections <inline-formula><mml:math id="M76"><mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi>P</mml:mi><mml:mo>&#x0003c;</mml:mo><mml:mn>.05</mml:mn></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula>.</p></sec></sec><sec sec-type="section" id="sec4"><title>4. DISCUSSION</title><p>The major changes of gastrointestinal function after TBI may be classified into four aspects: stress ulcer, gut motility dysfunction, disruption of gut barrier, and alterations of mucosal absorptive function. We previously reported that traumatic brain injury could lead to significant damages of gut structure and impairment of barrier function [<xref ref-type="bibr" rid="B4">4</xref>]. The intestinal inflammatory response following TBI is characterized by intestinal recruitments of neutrophils and monocytes through up-regulating of NF-<inline-formula><mml:math id="M77"><mml:mrow><mml:mi>&#x003ba;</mml:mi></mml:mrow></mml:math></inline-formula>B and releasing proinflammatory cytokines, which can lead to gut mucosal injury [<xref ref-type="bibr" rid="B5">5</xref>]. In this present study, we found that progesterone administration could decrease the NF-<inline-formula><mml:math id="M78"><mml:mrow><mml:mi>&#x003ba;</mml:mi></mml:mrow></mml:math></inline-formula>B binding activity, NF-<inline-formula><mml:math id="M79"><mml:mrow><mml:mi>&#x003ba;</mml:mi></mml:mrow></mml:math></inline-formula>B p65 protein expression and concentrations of IL-1<inline-formula><mml:math id="M80"><mml:mrow><mml:mi>&#x003b2;</mml:mi></mml:mrow></mml:math></inline-formula> and TNF-<inline-formula><mml:math id="M81"><mml:mrow><mml:mi>&#x003b1;</mml:mi></mml:mrow></mml:math></inline-formula> in the small bowl following TBI. It was also demonstrated that TBI-induced damages of gut structure were ameliorated when treated with progesterone.</p><p>Steroids are known regulators of NF-<inline-formula><mml:math id="M82"><mml:mrow><mml:mi>&#x003ba;</mml:mi></mml:mrow></mml:math></inline-formula>B activity [<xref ref-type="bibr" rid="B22">22</xref>, <xref ref-type="bibr" rid="B23">23</xref>]. Previous studies of the anti-inflammatory properties of progesterone have been largely characterized in female reproductive tissue, where progesterone down-regulates COX-2 via NF-<inline-formula><mml:math id="M83"><mml:mrow><mml:mi>&#x003ba;</mml:mi></mml:mrow></mml:math></inline-formula>B inhibition [<xref ref-type="bibr" rid="B24">24</xref>, <xref ref-type="bibr" rid="B25">25</xref>]. Progesterone has been reported to inhibit NF-<inline-formula><mml:math id="M84"><mml:mrow><mml:mi>&#x003ba;</mml:mi></mml:mrow></mml:math></inline-formula>B-mediated transcription in two ways. The better-characterized route is by promoting the production of the endogenous inhibitor of NF-<inline-formula><mml:math id="M85"><mml:mrow><mml:mi>&#x003ba;</mml:mi></mml:mrow></mml:math></inline-formula>B (I-<inline-formula><mml:math id="M86"><mml:mrow><mml:mi>&#x003ba;</mml:mi></mml:mrow></mml:math></inline-formula>B) [<xref ref-type="bibr" rid="B26">26</xref>]. Recent studies show that, when progesterone is present, the progesterone receptor forms a heterodimer with NF-<inline-formula><mml:math id="M87"><mml:mrow><mml:mi>&#x003ba;</mml:mi></mml:mrow></mml:math></inline-formula>B p65 and in turn inhibits binding of either transcription factor to its binding site [<xref ref-type="bibr" rid="B23">23</xref>]. In this present study, we found the NF-<inline-formula><mml:math id="M88"><mml:mrow><mml:mi>&#x003ba;</mml:mi></mml:mrow></mml:math></inline-formula>B binding activity in the nuclear protein was induced by TBI and repressed by progesterone administration. Moreover, we proved that the main up-regulated part of NF-<inline-formula><mml:math id="M89"><mml:mrow><mml:mi>&#x003ba;</mml:mi></mml:mrow></mml:math></inline-formula>B was the subunit p65, but not p50. After progesterone injections, intestinal level of NF-<inline-formula><mml:math id="M90"><mml:mrow><mml:mi>&#x003ba;</mml:mi></mml:mrow></mml:math></inline-formula>B p65 was decreased significantly. Although the current data have demonstrated that progesterone administration suppressed the TBI-induced intestinal NF-<inline-formula><mml:math id="M91"><mml:mrow><mml:mi>&#x003ba;</mml:mi></mml:mrow></mml:math></inline-formula>B up-regulation, changes about the expression of progesterone receptor (PR) and the whole signaling pathway in the gut remain unknown.</p><p>In the research regarding progesterone and NF-<inline-formula><mml:math id="M92"><mml:mrow><mml:mi>&#x003ba;</mml:mi></mml:mrow></mml:math></inline-formula>B, Pettus et al. [<xref ref-type="bibr" rid="B18">18</xref>] used Western blot techniques to analyze the effect of progesterone on cerebral expression of NF-<inline-formula><mml:math id="M93"><mml:mrow><mml:mi>&#x003ba;</mml:mi></mml:mrow></mml:math></inline-formula>B. They found NF-<inline-formula><mml:math id="M94"><mml:mrow><mml:mi>&#x003ba;</mml:mi></mml:mrow></mml:math></inline-formula>B p65 was increased in all injured animals and decreased by progesterone treatment in comparison to vehicle-treated animals. Measures of NF-<inline-formula><mml:math id="M95"><mml:mrow><mml:mi>&#x003ba;</mml:mi></mml:mrow></mml:math></inline-formula>B p50 showed no change after injury or progesterone treatment. Horie et al. [<xref ref-type="bibr" rid="B27">27</xref>] investigated the influence of progesterone on NF-<inline-formula><mml:math id="M96"><mml:mrow><mml:mi>&#x003ba;</mml:mi></mml:mrow></mml:math></inline-formula>B activation in vitro and suggested that progesterone could reduce TNF-<inline-formula><mml:math id="M97"><mml:mrow><mml:mi>&#x003b1;</mml:mi></mml:mrow></mml:math></inline-formula>-induced NF-<inline-formula><mml:math id="M98"><mml:mrow><mml:mi>&#x003ba;</mml:mi></mml:mrow></mml:math></inline-formula>B activation in endometriotic stromal cells. Another in vitro study [<xref ref-type="bibr" rid="B28">28</xref>] demonstrated that progesterone acted through multiple mechanisms to inhibit NF-<inline-formula><mml:math id="M99"><mml:mrow><mml:mi>&#x003ba;</mml:mi></mml:mrow></mml:math></inline-formula>B. First, there was direct inhibition of NF-<inline-formula><mml:math id="M100"><mml:mrow><mml:mi>&#x003ba;</mml:mi></mml:mrow></mml:math></inline-formula>B binding to DNA by PR which did not depend upon the presence of ligand and, presumably, was not related to the transcriptional activity of PR. Second, through the isoform progesterone receptor B (PRB), progesterone inhibited the transcription of tumor necrosis factor-<inline-formula><mml:math id="M101"><mml:mrow><mml:mi>&#x003b1;</mml:mi></mml:mrow></mml:math></inline-formula> related apoptosis inducing ligand (TRAIL, an activator of NF-<inline-formula><mml:math id="M102"><mml:mrow><mml:mi>&#x003ba;</mml:mi></mml:mrow></mml:math></inline-formula>B), and through PRA + PRB, progesterone inhibited the transcription of its receptor, TRAILR2. Finally, progesterone induced the transcription of A20 and ABIN-2 through PRB, resulting in the inactivation of free NF-<inline-formula><mml:math id="M103"><mml:mrow><mml:mi>&#x003ba;</mml:mi></mml:mrow></mml:math></inline-formula>B in the cytoplasm.</p><p>Cytokines are recognized as small and nonstructural proteins, which are pleiotropic and have multiple diverse biological activities [<xref ref-type="bibr" rid="B29">29</xref>]. Several studies have demonstrated that progesterone could modulate inflammatory cytokine production in vivo and vitro [<xref ref-type="bibr" rid="B30">30</xref>, <xref ref-type="bibr" rid="B31">31</xref>]. As revealed by He et al. [<xref ref-type="bibr" rid="B17">17</xref>], post-TBI progesterone administration might attenuate the production of proinflammatory cytokines, such as IL-1<inline-formula><mml:math id="M104"><mml:mrow><mml:mi>&#x003b2;</mml:mi></mml:mrow></mml:math></inline-formula> and TNF-<inline-formula><mml:math id="M105"><mml:mrow><mml:mi>&#x003b1;</mml:mi></mml:mrow></mml:math></inline-formula>, in the injured brain. Another research [<xref ref-type="bibr" rid="B32">32</xref>] indicated that the abundant expression of TNF-<inline-formula><mml:math id="M106"><mml:mrow><mml:mi>&#x003b1;</mml:mi></mml:mrow></mml:math></inline-formula> might be a molecular basis characteristic of leiomyomas in the human uterus and that progesterone might play a vital role in down-regulating the expression of TNF-<inline-formula><mml:math id="M107"><mml:mrow><mml:mi>&#x003b1;</mml:mi></mml:mrow></mml:math></inline-formula> in human uterine leiomyoma. Our study showed that intestinal TNF-<inline-formula><mml:math id="M108"><mml:mrow><mml:mi>&#x003b1;</mml:mi></mml:mrow></mml:math></inline-formula> and IL-1<inline-formula><mml:math id="M109"><mml:mrow><mml:mi>&#x003b2;</mml:mi></mml:mrow></mml:math></inline-formula> levels were significantly induced by TBI at 5 days after trauma. Progesterone administration following TBI could down-regulate the expressions of TNF-<inline-formula><mml:math id="M110"><mml:mrow><mml:mi>&#x003b1;</mml:mi></mml:mrow></mml:math></inline-formula> and IL-1<inline-formula><mml:math id="M111"><mml:mrow><mml:mi>&#x003b2;</mml:mi></mml:mrow></mml:math></inline-formula> in the gut. However, it is still unclear that how progesterone modulates the inflammatory signals and the whole mechanisms involved call for further research.</p><p>In summary, to the best of our knowledge, this is the first study to demonstrate the effects of progesterone on the intestinal expression of inflammatory agents after TBI. We found that progesterone administration could suppress the TBI-induced NF-<inline-formula><mml:math id="M112"><mml:mrow><mml:mi>&#x003ba;</mml:mi></mml:mrow></mml:math></inline-formula>B activation in the gut, decrease the intestinal production of proinflammatory cytokines, and protect ileum mucosa structure. These results suggest that the therapeutic benefit of post-TBI progesterone injections might be due to its inhibitory effects on NF-<inline-formula><mml:math id="M113"><mml:mrow><mml:mi>&#x003ba;</mml:mi></mml:mrow></mml:math></inline-formula>B activity and proinflammatory cytokines expression in the small bowl. </p></sec></body><back><ack><title>ACKNOWLEDGMENT</title><p> The authors thank Dr. Bo WU and Dr. Geng-bao FENG for their technical assistance.</p></ack><ref-list><ref id="B1"><label>1</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Grotz</surname><given-names>MRW</given-names></name><name><surname>Deitch</surname><given-names>EA</given-names></name><name><surname>Ding</surname><given-names>J</given-names></name><name><surname>Xu</surname><given-names>D</given-names></name><name><surname>Huang</surname><given-names>Q</given-names></name><name><surname>Regel</surname><given-names>G</given-names></name></person-group><article-title>Intestinal cytokine response after gut ischemia: role of gut barrier failure</article-title><source><italic>Annals of Surgery</italic></source><year>1999</year><volume>229</volume><issue>4</issue><fpage>478</fpage><lpage>486</lpage><pub-id pub-id-type="pmid">10203079</pub-id></citation></ref><ref id="B2"><label>2</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Faries</surname><given-names>PL</given-names></name><name><surname>Simon</surname><given-names>RJ</given-names></name><name><surname>Martella</surname><given-names>AT</given-names></name><name><surname>Lee</surname><given-names>MJ</given-names></name><name><surname>Machiedo</surname><given-names>GW</given-names></name></person-group><article-title>Intestinal permeability correlates with severity of injury in trauma patients</article-title><source><italic>The Journal of Trauma</italic></source><year>1998</year><volume>44</volume><issue>6</issue><fpage>1031</fpage><lpage>1036</lpage><pub-id pub-id-type="pmid">9637159</pub-id></citation></ref><ref id="B3"><label>3</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Swank</surname><given-names>GM</given-names></name><name><surname>Deitch</surname><given-names>EA</given-names></name></person-group><article-title>Role of the gut in multiple organ failure: bacterial translocation and permeability changes</article-title><source><italic>World Journal of Surgery</italic></source><year>1996</year><volume>20</volume><issue>4</issue><fpage>411</fpage><lpage>417</lpage><pub-id pub-id-type="pmid">8662128</pub-id></citation></ref><ref id="B4"><label>4</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hang</surname><given-names>C-H</given-names></name><name><surname>Shi</surname><given-names>J-X</given-names></name><name><surname>Li</surname><given-names>J-S</given-names></name><name><surname>Wu</surname><given-names>W</given-names></name><name><surname>Yin</surname><given-names>H-X</given-names></name></person-group><article-title>Alterations of intestinal mucosa structure and barrier function following traumatic brain injury in rats</article-title><source><italic>World Journal of Gastroenterology</italic></source><year>2003</year><volume>9</volume><issue>12</issue><fpage>2776</fpage><lpage>2781</lpage><pub-id pub-id-type="pmid">14669332</pub-id></citation></ref><ref id="B5"><label>5</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hang</surname><given-names>C-H</given-names></name><name><surname>Shi</surname><given-names>J-X</given-names></name><name><surname>Li</surname><given-names>J-S</given-names></name><name><surname>Li</surname><given-names>W-Q</given-names></name><name><surname>Wu</surname><given-names>W</given-names></name></person-group><article-title>Expressions of intestinal NF-<inline-formula><mml:math id="M114"><mml:mrow><mml:mi>&#x003ba;</mml:mi><mml:mtext>B</mml:mtext></mml:mrow></mml:math></inline-formula>, TNF-<inline-formula><mml:math id="M115"><mml:mrow><mml:mi>&#x003b1;</mml:mi></mml:mrow></mml:math></inline-formula>, and IL-6 following traumatic brain injury in rats</article-title><source><italic>Journal of Surgical Research</italic></source><year>2005</year><volume>123</volume><issue>2</issue><fpage>188</fpage><lpage>193</lpage><pub-id pub-id-type="pmid">15680377</pub-id></citation></ref><ref id="B6"><label>6</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>F</given-names></name><name><surname>Castranova</surname><given-names>V</given-names></name><name><surname>Shi</surname><given-names>X</given-names></name></person-group><article-title>New insights into the role of nuclear factor-<inline-formula><mml:math id="M116"><mml:mrow><mml:mi>&#x003ba;</mml:mi><mml:mtext>B</mml:mtext></mml:mrow></mml:math></inline-formula> in cell growth regulation</article-title><source><italic>American Journal of Pathology</italic></source><year>2001</year><volume>159</volume><issue>2</issue><fpage>387</fpage><lpage>397</lpage><pub-id pub-id-type="pmid">11485895</pub-id></citation></ref><ref id="B7"><label>7</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Castro-Caldas</surname><given-names>M</given-names></name><name><surname>Mendes</surname><given-names>AF</given-names></name><name><surname>Carvalho</surname><given-names>AP</given-names></name><name><surname>Duarte</surname><given-names>CB</given-names></name><name><surname>Lopes</surname><given-names>MC</given-names></name></person-group><article-title>Dexamethasone prevents interleukin-1<inline-formula><mml:math id="M117"><mml:mrow><mml:mi>&#x003b2;</mml:mi></mml:mrow></mml:math></inline-formula>-induced nuclear factor-<inline-formula><mml:math id="M118"><mml:mrow><mml:mi>&#x003ba;</mml:mi></mml:mrow></mml:math></inline-formula>B activation by upregulating I<inline-formula><mml:math id="M119"><mml:mrow><mml:mi>&#x003ba;</mml:mi></mml:mrow></mml:math></inline-formula>B-<inline-formula><mml:math id="M120"><mml:mrow><mml:mi>&#x003b1;</mml:mi></mml:mrow></mml:math></inline-formula> synthesis, in lymphoblastic cells</article-title><source><italic>Mediators of inflammation</italic></source><year>2003</year><volume>12</volume><issue>1</issue><fpage>37</fpage><lpage>46</lpage><pub-id pub-id-type="pmid">12745547</pub-id></citation></ref><ref id="B8"><label>8</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Homaidan</surname><given-names>FR</given-names></name><name><surname>Chakroun</surname><given-names>I</given-names></name><name><surname>El-Sabban</surname><given-names>ME</given-names></name></person-group><article-title>Regulation of nuclear factor-<inline-formula><mml:math id="M121"><mml:mrow><mml:mi>&#x003ba;</mml:mi><mml:mtext>B</mml:mtext></mml:mrow></mml:math></inline-formula> in intestinal epithelial cells in a cell model of inflammation</article-title><source><italic>Mediators of Inflammation</italic></source><year>2003</year><volume>12</volume><issue>5</issue><fpage>277</fpage><lpage>283</lpage><pub-id pub-id-type="pmid">14760934</pub-id></citation></ref><ref id="B9"><label>9</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Claud</surname><given-names>EC</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Petrof</surname><given-names>EO</given-names></name><name><surname>Sun</surname><given-names>J</given-names></name></person-group><article-title>Developmentally regulated tumor necrosis factor-<inline-formula><mml:math id="M122"><mml:mrow><mml:mi>&#x003b1;</mml:mi></mml:mrow></mml:math></inline-formula> induced nuclear factor <inline-formula><mml:math id="M123"><mml:mrow><mml:mi>&#x003ba;</mml:mi></mml:mrow></mml:math></inline-formula>B activation in intestinal epithelium</article-title><source><italic>American Journal of Physiology</italic></source><year>2007</year><volume>292</volume><issue>5</issue><fpage>G1411</fpage><lpage>G1419</lpage><pub-id pub-id-type="pmid">17307728</pub-id></citation></ref><ref id="B10"><label>10</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Baeuerle</surname><given-names>PA</given-names></name><name><surname>Baltimore</surname><given-names>D</given-names></name></person-group><article-title>Nf-<inline-formula><mml:math id="M124"><mml:mrow><mml:mi>&#x003ba;</mml:mi><mml:mtext>B</mml:mtext></mml:mrow></mml:math></inline-formula>: ten years after</article-title><source><italic>Cell</italic></source><year>1996</year><volume>87</volume><issue>1</issue><fpage>13</fpage><lpage>20</lpage><pub-id pub-id-type="pmid">8858144</pub-id></citation></ref><ref id="B11"><label>11</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>JW</given-names></name><name><surname>Lee</surname><given-names>MS</given-names></name><name><surname>Kim</surname><given-names>TH</given-names></name><etal/></person-group><article-title>Inhibitory effect of inflexinol on nitric oxide generation and iNOS expression via inhibition of NF-<inline-formula><mml:math id="M125"><mml:mrow><mml:mi>&#x003ba;</mml:mi><mml:mtext>B</mml:mtext></mml:mrow></mml:math></inline-formula> activation</article-title><source><italic>Mediators of Inflammation</italic></source><year>2007</year><volume>2007</volume><fpage>9 pages</fpage><pub-id pub-id-type="publisher-id">93148</pub-id></citation></ref><ref id="B12"><label>12</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fiocchi</surname><given-names>C</given-names></name></person-group><article-title>Intestinal inflammation: a complex interplay of immune and nonimmune cell interactions</article-title><source><italic>American Journal of Physiology</italic></source><year>1997</year><volume>273</volume><issue>4, part 1</issue><fpage>G769</fpage><lpage>G775</lpage><pub-id pub-id-type="pmid">9357817</pub-id></citation></ref><ref id="B13"><label>13</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pritts</surname><given-names>TA</given-names></name><name><surname>Moon</surname><given-names>MR</given-names></name><name><surname>Fischer</surname><given-names>JE</given-names></name><name><surname>Salzman</surname><given-names>AL</given-names></name><name><surname>Hasselgren</surname><given-names>P-O</given-names></name></person-group><article-title>Nuclear factor-<inline-formula><mml:math id="M126"><mml:mrow><mml:mi>&#x003ba;</mml:mi><mml:mtext>B</mml:mtext></mml:mrow></mml:math></inline-formula> is activated in intestinal mucosa during endotoxemia</article-title><source><italic>Archives of Surgery</italic></source><year>1998</year><volume>133</volume><issue>12</issue><fpage>1311</fpage><lpage>1315</lpage><pub-id pub-id-type="pmid">9865648</pub-id></citation></ref><ref id="B14"><label>14</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Neurath</surname><given-names>MF</given-names></name><name><surname>Pettersson</surname><given-names>S</given-names></name><name><surname>Meyer zum Buschenfelde</surname><given-names>K-H</given-names></name><name><surname>Strober</surname><given-names>W</given-names></name></person-group><article-title>Local administration of antisense phosphorothioate oligonucleotides to the p65 subunit of NF-<inline-formula><mml:math id="M127"><mml:mrow><mml:mi>&#x003ba;</mml:mi><mml:mtext>B</mml:mtext></mml:mrow></mml:math></inline-formula> abrogates established experimental colitis in mice</article-title><source><italic>Nature Medicine</italic></source><year>1996</year><volume>2</volume><issue>9</issue><fpage>998</fpage><lpage>1004</lpage></citation></ref><ref id="B15"><label>15</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Stein</surname><given-names>DG</given-names></name></person-group><article-title>Brain damage, sex hormones and recovery: a new role for progesterone and estrogen?</article-title><source><italic>Trends in Neurosciences</italic></source><year>2001</year><volume>24</volume><issue>7</issue><fpage>386</fpage><lpage>391</lpage><pub-id pub-id-type="pmid">11410269</pub-id></citation></ref><ref id="B16"><label>16</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wright</surname><given-names>DW</given-names></name><name><surname>Kellermann</surname><given-names>AL</given-names></name><name><surname>Hertzberg</surname><given-names>VS</given-names></name><etal/></person-group><article-title>ProTECT: a randomized clinical trial of progesterone for acute traumatic brain injury</article-title><source><italic>Annals of Emergency Medicine</italic></source><year>2007</year><volume>49</volume><issue>4</issue><fpage>391</fpage><lpage>402</lpage><pub-id pub-id-type="pmid">17011666</pub-id></citation></ref><ref id="B17"><label>17</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>J</given-names></name><name><surname>Evans</surname><given-names>C-O</given-names></name><name><surname>Hoffman</surname><given-names>SW</given-names></name><name><surname>Oyesiku</surname><given-names>NM</given-names></name><name><surname>Stein</surname><given-names>DG</given-names></name></person-group><article-title>Progesterone and allopregnanolone reduce inflammatory cytokines after traumatic brain injury</article-title><source><italic>Experimental Neurology</italic></source><year>2004</year><volume>189</volume><issue>2</issue><fpage>404</fpage><lpage>412</lpage><pub-id pub-id-type="pmid">15380490</pub-id></citation></ref><ref id="B18"><label>18</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pettus</surname><given-names>EH</given-names></name><name><surname>Wright</surname><given-names>DW</given-names></name><name><surname>Stein</surname><given-names>DG</given-names></name><name><surname>Hoffman</surname><given-names>SW</given-names></name></person-group><article-title>Progesterone treatment inhibits the inflammatory agents that accompany traumatic brain injury</article-title><source><italic>Brain Research</italic></source><year>2005</year><volume>1049</volume><issue>1</issue><fpage>112</fpage><lpage>119</lpage><pub-id pub-id-type="pmid">15932748</pub-id></citation></ref><ref id="B19"><label>19</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Feeney</surname><given-names>DM</given-names></name><name><surname>Boyeson</surname><given-names>MG</given-names></name><name><surname>Linn</surname><given-names>RT</given-names></name><name><surname>Murraya</surname><given-names>HM</given-names></name><name><surname>Daila</surname><given-names>WG</given-names></name></person-group><article-title>Responses to cortical injury&#x02014;I: methodology and local effects of contusions in the rat</article-title><source><italic>Brain Research</italic></source><year>1981</year><volume>211</volume><issue>1</issue><fpage>67</fpage><lpage>77</lpage><pub-id pub-id-type="pmid">7225844</pub-id></citation></ref><ref id="B20"><label>20</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Djebaili</surname><given-names>M</given-names></name><name><surname>Hoffman</surname><given-names>SW</given-names></name><name><surname>Stein</surname><given-names>DG</given-names></name></person-group><article-title>Allopregnanolone and progesterone decrease cell death and cognitive deficits after a contusion of the rat pre-frontal cortex</article-title><source><italic>Neuroscience</italic></source><year>2004</year><volume>123</volume><issue>2</issue><fpage>349</fpage><lpage>359</lpage><pub-id pub-id-type="pmid">14698743</pub-id></citation></ref><ref id="B21"><label>21</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Goss</surname><given-names>CW</given-names></name><name><surname>Hoffman</surname><given-names>SW</given-names></name><name><surname>Stein</surname><given-names>DG</given-names></name></person-group><article-title>Behavioral effects and anatomic correlates after brain injury: a progesterone dose-response study</article-title><source><italic>Pharmacology Biochemistry and Behavior</italic></source><year>2003</year><volume>76</volume><issue>2</issue><fpage>231</fpage><lpage>242</lpage></citation></ref><ref id="B22"><label>22</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>De Bosscher</surname><given-names>K</given-names></name><name><surname>Schmitz</surname><given-names>ML</given-names></name><name><surname>Berghe</surname><given-names>WV</given-names></name><name><surname>Plaisance</surname><given-names>S</given-names></name><name><surname>Fiers</surname><given-names>W</given-names></name><name><surname>Haegeman</surname><given-names>G</given-names></name></person-group><article-title>Glucocorticoid-mediated repression of nuclear factor-<inline-formula><mml:math id="M128"><mml:mrow><mml:mi>&#x003ba;</mml:mi><mml:mtext>B</mml:mtext></mml:mrow></mml:math></inline-formula>-dependent transcription involves direct interference with transactivation</article-title><source><italic>Proceedings of the National Academy of Sciences of the United States of America</italic></source><year>1997</year><volume>94</volume><issue>25</issue><fpage>13504</fpage><lpage>13509</lpage><pub-id pub-id-type="pmid">9391055</pub-id></citation></ref><ref id="B23"><label>23</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kalkhoven</surname><given-names>E</given-names></name><name><surname>Wissink</surname><given-names>S</given-names></name><name><surname>van der Saag</surname><given-names>PT</given-names></name><name><surname>van der Burg</surname><given-names>B</given-names></name></person-group><article-title>Negative interaction between the RelA(p65) subunit of NF-<inline-formula><mml:math id="M129"><mml:mrow><mml:mi>&#x003ba;</mml:mi><mml:mtext>B</mml:mtext></mml:mrow></mml:math></inline-formula> and the progesterone receptor</article-title><source><italic>The Journal of Biological Chemistry</italic></source><year>1996</year><volume>271</volume><issue>11</issue><fpage>6217</fpage><lpage>6224</lpage><pub-id pub-id-type="pmid">8626413</pub-id></citation></ref><ref id="B24"><label>24</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Allport</surname><given-names>VC</given-names></name><name><surname>Slater</surname><given-names>DM</given-names></name><name><surname>Newton</surname><given-names>R</given-names></name><name><surname>Bennett</surname><given-names>PR</given-names></name></person-group><article-title>NF-<inline-formula><mml:math id="M130"><mml:mrow><mml:mi>&#x003ba;</mml:mi><mml:mtext>B</mml:mtext></mml:mrow></mml:math></inline-formula> and AP-1 are required for cyclo-oxygenase 2 gene expression in amnion epithelial cell line (WISH)</article-title><source><italic>Molecular Human Reproduction</italic></source><year>2000</year><volume>6</volume><issue>6</issue><fpage>561</fpage><lpage>565</lpage><pub-id pub-id-type="pmid">10825375</pub-id></citation></ref><ref id="B25"><label>25</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Allport</surname><given-names>VC</given-names></name><name><surname>Pieber</surname><given-names>D</given-names></name><name><surname>Slater</surname><given-names>DM</given-names></name><name><surname>Newton</surname><given-names>R</given-names></name><name><surname>White</surname><given-names>JO</given-names></name><name><surname>Bennett</surname><given-names>PR</given-names></name></person-group><article-title>Human labour is associated with nuclear factor-<inline-formula><mml:math id="M131"><mml:mrow><mml:mi>&#x003ba;</mml:mi><mml:mtext>B</mml:mtext></mml:mrow></mml:math></inline-formula> activity which mediates cyclo-oxygenase-2 expression and is involved with the &#x02018;functional progesterone withdrawal&#x02019;</article-title><source><italic>Molecular Human Reproduction</italic></source><year>2001</year><volume>7</volume><issue>6</issue><fpage>581</fpage><lpage>586</lpage><pub-id pub-id-type="pmid">11385114</pub-id></citation></ref><ref id="B26"><label>26</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wissink</surname><given-names>S</given-names></name><name><surname>van Heerde</surname><given-names>EC</given-names></name><name><surname>van der Burg</surname><given-names>B</given-names></name><name><surname>van der Saag</surname><given-names>PT</given-names></name></person-group><article-title>A dual mechanism mediates repression of NF-<inline-formula><mml:math id="M132"><mml:mrow><mml:mi>&#x003ba;</mml:mi><mml:mtext>B</mml:mtext></mml:mrow></mml:math></inline-formula> activity by glucocorticoids</article-title><source><italic>Molecular Endocrinology</italic></source><year>1998</year><volume>12</volume><issue>3</issue><fpage>355</fpage><lpage>363</lpage><pub-id pub-id-type="pmid">9514153</pub-id></citation></ref><ref id="B27"><label>27</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Horie</surname><given-names>S</given-names></name><name><surname>Harada</surname><given-names>T</given-names></name><name><surname>Mitsunari</surname><given-names>M</given-names></name><name><surname>Taniguchi</surname><given-names>F</given-names></name><name><surname>Iwabe</surname><given-names>T</given-names></name><name><surname>Terakawa</surname><given-names>N</given-names></name></person-group><article-title>Progesterone and progestational compounds attenuate tumor necrosis factor <inline-formula><mml:math id="M133"><mml:mrow><mml:mi>&#x003b1;</mml:mi></mml:mrow></mml:math></inline-formula>-induced interleukin-8 production via nuclear factor <inline-formula><mml:math id="M134"><mml:mrow><mml:mi>&#x003ba;</mml:mi></mml:mrow></mml:math></inline-formula>B inactivation in endometriotic stromal cells</article-title><source><italic>Fertility and Sterility</italic></source><year>2005</year><volume>83</volume><issue>5</issue><fpage>1530</fpage><lpage>1535</lpage><pub-id pub-id-type="pmid">15866594</pub-id></citation></ref><ref id="B28"><label>28</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Davies</surname><given-names>S</given-names></name><name><surname>Dai</surname><given-names>D</given-names></name><name><surname>Feldman</surname><given-names>I</given-names></name><name><surname>Pickett</surname><given-names>G</given-names></name><name><surname>Leslie</surname><given-names>KK</given-names></name></person-group><article-title>Identification of a novel mechanism of NF-<inline-formula><mml:math id="M135"><mml:mrow><mml:mi>&#x003ba;</mml:mi><mml:mtext>B</mml:mtext></mml:mrow></mml:math></inline-formula> inactivation by progesterone through progesterone receptors in Hec50co poorly differentiated endometrial cancer cells: induction of A20 and ABIN-2</article-title><source><italic>Gynecologic Oncology</italic></source><year>2004</year><volume>94</volume><issue>2</issue><fpage>463</fpage><lpage>470</lpage><pub-id pub-id-type="pmid">15297189</pub-id></citation></ref><ref id="B29"><label>29</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sercombe</surname><given-names>R</given-names></name><name><surname>Tran Dinh</surname><given-names>YR</given-names></name><name><surname>Gomis</surname><given-names>P</given-names></name></person-group><article-title>Cerebrovascular inflammation following subarachnoid hemorrhage</article-title><source><italic>The Japanese Journal of Pharmacology</italic></source><year>2002</year><volume>88</volume><issue>3</issue><fpage>227</fpage><lpage>249</lpage></citation></ref><ref id="B30"><label>30</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gotkin</surname><given-names>JL</given-names></name><name><surname>Celver</surname><given-names>J</given-names></name><name><surname>McNutt</surname><given-names>P</given-names></name><etal/></person-group><article-title>Progesterone reduces lipopolysaccharide induced interleukin-6 secretion in fetoplacental chorionic arteries, fractionated cord blood, and maternal mononuclear cells</article-title><source><italic>American Journal of Obstetrics and Gynecology</italic></source><year>2006</year><volume>195</volume><issue>4</issue><fpage>1015</fpage><lpage>1019</lpage><pub-id pub-id-type="pmid">17000234</pub-id></citation></ref><ref id="B31"><label>31</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shields</surname><given-names>AD</given-names></name><name><surname>Wright</surname><given-names>J</given-names></name><name><surname>Paonessa</surname><given-names>DJ</given-names></name><etal/></person-group><article-title>Progesterone modulation of inflammatory cytokine production in a fetoplacental artery explant model</article-title><source><italic>American Journal of Obstetrics and Gynecology</italic></source><year>2005</year><volume>193</volume><issue>3</issue><supplement>1</supplement><fpage>1144</fpage><lpage>1148</lpage><pub-id pub-id-type="pmid">16157127</pub-id></citation></ref><ref id="B32"><label>32</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kurachi</surname><given-names>O</given-names></name><name><surname>Matsuo</surname><given-names>H</given-names></name><name><surname>Samoto</surname><given-names>T</given-names></name><name><surname>Maruo</surname><given-names>T</given-names></name></person-group><article-title>Tumor necrosis factor-<inline-formula><mml:math id="M136"><mml:mrow><mml:mi>&#x003b1;</mml:mi></mml:mrow></mml:math></inline-formula> expression in human uterine leiomyoma and its down-regulation by progesterone</article-title><source><italic>The Journal of Clinical Endocrinology and Metabolism</italic></source><year>2001</year><volume>86</volume><issue>5</issue><fpage>2275</fpage><lpage>2280</lpage><pub-id pub-id-type="pmid">11344239</pub-id></citation></ref></ref-list></back><floats-wrap><fig position="float" id="fig1"><label>Figure 1</label><caption><p>NF-<inline-formula><mml:math id="M137" overflow="scroll"><mml:mrow><mml:mi>&#x003ba;</mml:mi></mml:mrow></mml:math></inline-formula>B activity in the ileum tissue in SV group (sham + vehicle, <inline-formula><mml:math id="M138" overflow="scroll"><mml:mrow><mml:mi>n</mml:mi><mml:mo>&#x02062;</mml:mo><mml:mo>=</mml:mo><mml:mtext>&#x02009;</mml:mtext><mml:mn>6</mml:mn></mml:mrow></mml:math></inline-formula>), LV group (lesion + vehicle, <inline-formula><mml:math id="M139" overflow="scroll"><mml:mrow><mml:mi>n</mml:mi><mml:mo>&#x02062;</mml:mo><mml:mo>=</mml:mo><mml:mtext>&#x02009;</mml:mtext><mml:mn>6</mml:mn></mml:mrow></mml:math></inline-formula>), and LP group (lesion + progesterone, <inline-formula><mml:math id="M140" overflow="scroll"><mml:mrow><mml:mi>n</mml:mi><mml:mo>&#x02062;</mml:mo><mml:mo>=</mml:mo><mml:mtext>&#x02009;</mml:mtext><mml:mn>6</mml:mn></mml:mrow></mml:math></inline-formula>). (Upper) EMSA autoradiography of NF-<inline-formula><mml:math id="M141" overflow="scroll"><mml:mrow><mml:mi>&#x003ba;</mml:mi></mml:mrow></mml:math></inline-formula>B DNA binding. (Bottom) Levels of NF-<inline-formula><mml:math id="M142" overflow="scroll"><mml:mrow><mml:mi>&#x003ba;</mml:mi></mml:mrow></mml:math></inline-formula>B DNA binding activity quantified by computer-assisted densitometric scanning and expressed as an arbitrary densitometric units (ADU). As compared with SV group, NF-<inline-formula><mml:math id="M143" overflow="scroll"><mml:mrow><mml:mi>&#x003ba;</mml:mi></mml:mrow></mml:math></inline-formula>B binding activity measured by EMSA was significantly increased in LV group. Compared to LV group, progesterone significantly suppressed NF-<inline-formula><mml:math id="M144" overflow="scroll"><mml:mrow><mml:mi>&#x003ba;</mml:mi></mml:mrow></mml:math></inline-formula>B activation in LP group. **<inline-formula><mml:math id="M145" overflow="scroll"><mml:mrow><mml:mi>P</mml:mi><mml:mo>&#x02062;</mml:mo><mml:mo>&#x0003c;</mml:mo><mml:mtext>&#x02009;</mml:mtext><mml:mn>.01</mml:mn></mml:mrow></mml:math></inline-formula> versus SV group, <sup>#</sup><inline-formula><mml:math id="M146" overflow="scroll"><mml:mrow><mml:mi>P</mml:mi><mml:mo>&#x02062;</mml:mo><mml:mo>&#x0003c;</mml:mo><mml:mtext>&#x02009;</mml:mtext><mml:mn>.05</mml:mn></mml:mrow></mml:math></inline-formula> versus LV group.</p></caption><graphic xlink:href="MI2007-93431.001" alt-version="no" position="float" xlink:type="simple"/></fig><fig position="float" id="fig2"><label>Figure 2</label><caption><p>Expression of NF-<inline-formula><mml:math id="M147" overflow="scroll"><mml:mrow><mml:mi>&#x003ba;</mml:mi></mml:mrow></mml:math></inline-formula>B p65 in the small intestines in SV group (sham + vehicle, <inline-formula><mml:math id="M148" overflow="scroll"><mml:mrow><mml:mi>n</mml:mi><mml:mo>&#x02062;</mml:mo><mml:mo>=</mml:mo><mml:mtext>&#x02009;</mml:mtext><mml:mn>6</mml:mn></mml:mrow></mml:math></inline-formula>), LV group (lesion + vehicle, <inline-formula><mml:math id="M149" overflow="scroll"><mml:mrow><mml:mi>n</mml:mi><mml:mo>&#x02062;</mml:mo><mml:mo>=</mml:mo><mml:mtext>&#x02009;</mml:mtext><mml:mn>6</mml:mn></mml:mrow></mml:math></inline-formula>), and LP group (lesion + progesterone, <inline-formula><mml:math id="M150" overflow="scroll"><mml:mrow><mml:mi>n</mml:mi><mml:mo>&#x02062;</mml:mo><mml:mo>=</mml:mo><mml:mtext>&#x02009;</mml:mtext><mml:mn>6</mml:mn></mml:mrow></mml:math></inline-formula>). (a) Rats of SV group showing low NF-<inline-formula><mml:math id="M151" overflow="scroll"><mml:mrow><mml:mi>&#x003ba;</mml:mi></mml:mrow></mml:math></inline-formula>B p65 immunoreactivity; (b) Rats of LV group showing increased NF-<inline-formula><mml:math id="M152" overflow="scroll"><mml:mrow><mml:mi>&#x003ba;</mml:mi></mml:mrow></mml:math></inline-formula>B p65 immunoreactivity stained as brown; (c) Rats of LP group showing less NF-<inline-formula><mml:math id="M153" overflow="scroll"><mml:mrow><mml:mi>&#x003ba;</mml:mi></mml:mrow></mml:math></inline-formula>B p65 immunoreactivity than LV group (scar bar, 100&#x02009;<italic>&#x003bc;</italic>m).</p></caption><graphic xlink:href="MI2007-93431.002" alt-version="no" position="float" xlink:type="simple"/></fig><fig position="float" id="fig3"><label>Figure 3</label><caption><p>Expression of NF-<inline-formula><mml:math id="M154" overflow="scroll"><mml:mrow><mml:mi>&#x003ba;</mml:mi></mml:mrow></mml:math></inline-formula>B p50 in the small intestines in SV group (sham + vehicle, <inline-formula><mml:math id="M155" overflow="scroll"><mml:mrow><mml:mi>n</mml:mi><mml:mo>&#x02062;</mml:mo><mml:mo>=</mml:mo><mml:mtext>&#x02009;</mml:mtext><mml:mn>6</mml:mn></mml:mrow></mml:math></inline-formula>), LV group (lesion + vehicle, <inline-formula><mml:math id="M156" overflow="scroll"><mml:mrow><mml:mi>n</mml:mi><mml:mo>=</mml:mo><mml:mn>6</mml:mn></mml:mrow></mml:math></inline-formula>), and LP group (lesion + progesterone, <inline-formula><mml:math id="M157" overflow="scroll"><mml:mrow><mml:mi>n</mml:mi><mml:mo>&#x02062;</mml:mo><mml:mo>=</mml:mo><mml:mtext>&#x02009;</mml:mtext><mml:mn>6</mml:mn></mml:mrow></mml:math></inline-formula>). Very low NF-<inline-formula><mml:math id="M158" overflow="scroll"><mml:mrow><mml:mi>&#x003ba;</mml:mi></mml:mrow></mml:math></inline-formula>B p50 immunoreactivity was shown in the ileum tissue of the three groups (scar bar, 100&#x02009;<italic>&#x003bc;</italic>m).</p></caption><graphic xlink:href="MI2007-93431.003" alt-version="no" position="float" xlink:type="simple"/></fig><fig position="float" id="fig4"><label>Figure 4</label><caption><p>NF-<inline-formula><mml:math id="M159" overflow="scroll"><mml:mrow><mml:mi>&#x003ba;</mml:mi></mml:mrow></mml:math></inline-formula>B p65 and p50 grades in the small intestines in SV group (sham + vehicle, <inline-formula><mml:math id="M160" overflow="scroll"><mml:mrow><mml:mi>n</mml:mi><mml:mo>&#x02062;</mml:mo><mml:mo>=</mml:mo><mml:mtext>&#x02009;</mml:mtext><mml:mn>6</mml:mn></mml:mrow></mml:math></inline-formula>), LV group (lesion + vehicle, <inline-formula><mml:math baseline="1" height="14" width="40" altimg="C:\WINDOWS\Temp\MMLIMG53636.png" id="M161" overflow="scroll"><mml:mrow><mml:mi>n</mml:mi><mml:mo>&#x02062;</mml:mo><mml:mo>=</mml:mo><mml:mtext>&#x02009;</mml:mtext><mml:mn>6</mml:mn></mml:mrow></mml:math></inline-formula>), and LP group (lesion + progesterone, <inline-formula><mml:math id="M162" overflow="scroll"><mml:mrow><mml:mi>n</mml:mi><mml:mo>&#x02062;</mml:mo><mml:mo>=</mml:mo><mml:mtext>&#x02009;</mml:mtext><mml:mn>6</mml:mn></mml:mrow></mml:math></inline-formula>). Administration of progesterone remarkably inhibited TBI-induced up-regulation of NF-<inline-formula><mml:math id="M163" overflow="scroll"><mml:mrow><mml:mi>&#x003ba;</mml:mi></mml:mrow></mml:math></inline-formula>B p65 expression in rat ileum tissue. The NF-<inline-formula><mml:math id="M164" overflow="scroll"><mml:mrow><mml:mi>&#x003ba;</mml:mi></mml:mrow></mml:math></inline-formula>B p50 expression in ileum was not significantly different among groups of SV, LV and LP. **<inline-formula><mml:math id="M165" overflow="scroll"><mml:mrow><mml:mi>P</mml:mi><mml:mo>&#x02062;</mml:mo><mml:mo>&#x0003c;</mml:mo><mml:mtext>&#x02009;</mml:mtext><mml:mn>.01</mml:mn></mml:mrow></mml:math></inline-formula> versus SV group; <sup>#</sup><inline-formula><mml:math id="M166" overflow="scroll"><mml:mrow><mml:mi>P</mml:mi><mml:mo>&#x02062;</mml:mo><mml:mo>&#x0003c;</mml:mo><mml:mtext>&#x02009;</mml:mtext><mml:mn>.05</mml:mn></mml:mrow></mml:math></inline-formula> versus LV group.</p></caption><graphic xlink:href="MI2007-93431.004" alt-version="no" position="float" xlink:type="simple"/></fig><fig position="float" id="fig5"><label>Figure 5</label><caption><p>Changes of inflammatory mediators in the small intestines as determined by ELISA in SV group (sham + vehicle, <inline-formula><mml:math id="M167" overflow="scroll"><mml:mrow><mml:mi>n</mml:mi><mml:mo>&#x02062;</mml:mo><mml:mo>=</mml:mo><mml:mtext>&#x02009;</mml:mtext><mml:mn>6</mml:mn></mml:mrow></mml:math></inline-formula>), LV group (lesion + vehicle, <inline-formula><mml:math id="M168" overflow="scroll"><mml:mrow><mml:mi>n</mml:mi><mml:mo>&#x02062;</mml:mo><mml:mo>=</mml:mo><mml:mtext>&#x02009;</mml:mtext><mml:mn>6</mml:mn></mml:mrow></mml:math></inline-formula>), and LP group (lesion + progesterone, <inline-formula><mml:math id="M169" overflow="scroll"><mml:mrow><mml:mi>n</mml:mi><mml:mo>&#x02062;</mml:mo><mml:mo>=</mml:mo><mml:mtext>&#x02009;</mml:mtext><mml:mn>6</mml:mn></mml:mrow></mml:math></inline-formula>). TBI could induce the significantly increased concentrations of IL-1<inline-formula><mml:math id="M170" overflow="scroll"><mml:mrow><mml:mi>&#x003b2;</mml:mi></mml:mrow></mml:math></inline-formula> and TNF-<inline-formula><mml:math id="M171" overflow="scroll"><mml:mrow><mml:mi>&#x003b1;</mml:mi></mml:mrow></mml:math></inline-formula> in rat ileum tissue. In LP group, the intestinal concentrations of IL-1<inline-formula><mml:math id="M172" overflow="scroll"><mml:mrow><mml:mi>&#x003b2;</mml:mi></mml:mrow></mml:math></inline-formula> and TNF-<inline-formula><mml:math id="M173" overflow="scroll"><mml:mrow><mml:mi>&#x003b1;</mml:mi></mml:mrow></mml:math></inline-formula> were markedly down-regulated as compared with that of LV group. **<inline-formula><mml:math id="M174" overflow="scroll"><mml:mrow><mml:mi>P</mml:mi><mml:mo>&#x02062;</mml:mo><mml:mo>&#x0003c;</mml:mo><mml:mtext>&#x02009;</mml:mtext><mml:mn>.01</mml:mn></mml:mrow></mml:math></inline-formula> and *<inline-formula><mml:math id="M175" overflow="scroll"><mml:mrow><mml:mi>P</mml:mi><mml:mo>&#x02062;</mml:mo><mml:mo>&#x0003c;</mml:mo><mml:mtext>&#x02009;</mml:mtext><mml:mn>.05</mml:mn></mml:mrow></mml:math></inline-formula> versus SV group; <sup>#</sup><inline-formula><mml:math id="M176" overflow="scroll"><mml:mrow><mml:mi>P</mml:mi><mml:mo>&#x02062;</mml:mo><mml:mo>&#x0003c;</mml:mo><mml:mtext>&#x02009;</mml:mtext><mml:mn>.05</mml:mn></mml:mrow></mml:math></inline-formula> versus LV group.</p></caption><graphic xlink:href="MI2007-93431.005" alt-version="no" position="float" xlink:type="simple"/></fig><table-wrap position="float" id="tab1"><label>Table 1</label><caption><p>Changes in villous height, diameter, crypt depth, and surface area of mucosa (Values were expressed as mean &#x000b1; SD.)</p></caption><table><thead><tr><th align="center" rowspan="1" colspan="1">Groups</th><th align="center" rowspan="1" colspan="1">Villous height (<italic>&#x003bc;</italic>m)</th><th align="center" rowspan="1" colspan="1">Villous diameter (<italic>&#x003bc;</italic>m)</th><th align="center" rowspan="1" colspan="1">Crypt depth (<italic>&#x003bc;</italic>m)</th><th align="center" rowspan="1" colspan="1">Surface area (mm<sup>2</sup>)</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">SV</td><td align="center" rowspan="1" colspan="1"><inline-formula><mml:math id="M177" overflow="scroll"><mml:mn>294.1</mml:mn><mml:mo>&#x000b1;</mml:mo><mml:mn>41.8</mml:mn></mml:math></inline-formula></td><td align="center" rowspan="1" colspan="1"><inline-formula><mml:math id="M178" overflow="scroll"><mml:mn>63.0</mml:mn><mml:mo>&#x000b1;</mml:mo><mml:mn>15.5</mml:mn></mml:math></inline-formula></td><td align="center" rowspan="1" colspan="1"><inline-formula><mml:math id="M179" overflow="scroll"><mml:mn>80.2</mml:mn><mml:mo>&#x000b1;</mml:mo><mml:mn>12.5</mml:mn></mml:math></inline-formula></td><td align="center" rowspan="1" colspan="1"><inline-formula><mml:math id="M180" overflow="scroll"><mml:mn>0.0577</mml:mn><mml:mo>&#x000b1;</mml:mo><mml:mn>0.0155</mml:mn></mml:math></inline-formula></td></tr><tr><td rowspan="1" colspan="1">LV</td><td align="center" rowspan="1" colspan="1"><inline-formula><mml:math id="M181" overflow="scroll"><mml:mn>216.8</mml:mn><mml:mo>&#x000b1;</mml:mo><mml:mn>12.3</mml:mn></mml:math></inline-formula>*</td><td align="center" rowspan="1" colspan="1"><inline-formula><mml:math id="M182" overflow="scroll"><mml:mn>54.2</mml:mn><mml:mo>&#x000b1;</mml:mo><mml:mn>2.0</mml:mn></mml:math></inline-formula></td><td align="center" rowspan="1" colspan="1"><inline-formula><mml:math id="M183" overflow="scroll"><mml:mn>55.2</mml:mn><mml:mo>&#x000b1;</mml:mo><mml:mn>1.8</mml:mn></mml:math></inline-formula>*</td><td align="center" rowspan="1" colspan="1"><inline-formula><mml:math id="M184" overflow="scroll"><mml:mn>0.0370</mml:mn><mml:mo>&#x000b1;</mml:mo><mml:mn>0.0034</mml:mn></mml:math></inline-formula></td></tr><tr><td rowspan="1" colspan="1">LP</td><td align="center" rowspan="1" colspan="1"><inline-formula><mml:math id="M185" overflow="scroll"><mml:mn>257.5</mml:mn><mml:mo>&#x000b1;</mml:mo><mml:mn>40.3</mml:mn></mml:math></inline-formula><sup>##</sup></td><td align="center" rowspan="1" colspan="1"><inline-formula><mml:math id="M186" overflow="scroll"><mml:mn>54.4</mml:mn><mml:mo>&#x000b1;</mml:mo><mml:mn>5.6</mml:mn></mml:math></inline-formula></td><td align="center" rowspan="1" colspan="1"><inline-formula><mml:math id="M187" overflow="scroll"><mml:mn>66.5</mml:mn><mml:mo>&#x000b1;</mml:mo><mml:mn>1.6</mml:mn></mml:math></inline-formula><sup>##</sup></td><td align="center" rowspan="1" colspan="1"><inline-formula><mml:math id="M188" overflow="scroll"><mml:mn>0.0448</mml:mn><mml:mo>&#x000b1;</mml:mo><mml:mn>0.0053</mml:mn></mml:math></inline-formula><sup>#</sup></td></tr></tbody></table><table-wrap-foot><fn><p>*<inline-formula><mml:math id="M189" overflow="scroll"><mml:mrow><mml:mi>P</mml:mi><mml:mo>&#x02062;</mml:mo><mml:mo>&#x0003c;</mml:mo><mml:mtext>&#x02009;</mml:mtext><mml:mn>.05</mml:mn></mml:mrow></mml:math></inline-formula> versus SV group.</p></fn><fn><p><sup>#</sup><inline-formula><mml:math id="M190" overflow="scroll"><mml:mrow><mml:mi>P</mml:mi><mml:mo>&#x02062;</mml:mo><mml:mo>&#x0003c;</mml:mo><mml:mtext>&#x02009;</mml:mtext><mml:mn>.05</mml:mn></mml:mrow></mml:math></inline-formula> and <sup>##</sup><inline-formula><mml:math id="M191" overflow="scroll"><mml:mrow><mml:mi>P</mml:mi><mml:mo>&#x02062;</mml:mo><mml:mo>&#x0003c;</mml:mo><mml:mtext>&#x02009;</mml:mtext><mml:mn>.01</mml:mn></mml:mrow></mml:math></inline-formula> versus LV group.</p></fn></table-wrap-foot></table-wrap></floats-wrap></article> 